Groopman, E. E. et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl. J. Med. 380, 142–151 (2019).
Article CAS PubMed Google Scholar
Claus, L. R., Snoek, R., Knoers, N. V. A. M. & van Eerde, A. M. Review of genetic testing in kidney disease patients: diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups. Am. J. Med. Genet. Part C Semin. Med. Genet. 190, 358–376 (2022).
Article CAS PubMed Google Scholar
Doreille, A. et al. Exome-first strategy in adult patients with CKD: a cohort study. Kidney Int. Rep. 8, 596–605 (2023).
Robert, T. et al. Diagnosis of kidney diseases of unknown etiology through biopsy-genetic analysis. Kidney Int. Rep. 8, 2077–2087 (2023).
Article PubMed PubMed Central Google Scholar
Robert, T. et al. Beyond the kidney biopsy: genomic approach to undetermined kidney diseases. Clin. Kidney J. 17, sfad099 (2024).
Vivante, A. Genetics of chronic kidney disease. N. Engl. J. Med. 391, 627–639 (2024).
Article CAS PubMed Google Scholar
Smith, E. D. et al. A retrospective review of multiple findings in diagnostic exome sequencing: half are distinct and half are overlapping diagnoses. Genet. Med. 21, 2199–2207 (2019).
Article PubMed PubMed Central Google Scholar
Köttgen, A. et al. Genetics in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 101, 1126–1141 (2022).
Jayasinghe, K. et al. Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet. Med. 23, 183–191 (2021).
Mallett, A. J. Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future. Curr. Opin. Nephrol. Hypertens. 31, 541–547 (2022).
Article CAS PubMed PubMed Central Google Scholar
Doreille, A., Rafat, C., Rondeau, E. & Mesnard, L. How I treat thrombotic microangiopathy in the era of rapid genomics. Blood 141, 147–155 (2023).
Article CAS PubMed Google Scholar
Yousfi, N. et al. Genomic analysis of adult thrombotic microangiopathies in less than 3 days: from rapid to fast genomics to treatment. Blood J. 144, 2266–2269 (2024).
Vitsios, D., Dhindsa, R. S., Middleton, L., Gussow, A. B. & Petrovski, S. Prioritizing non-coding regions based on human genomic constraint and sequence context with deep learning. Nat. Commun. 12, 1504 (2021).
Article CAS PubMed PubMed Central Google Scholar
Zipfel, P. F., Wiech, T., Stea, E. D. & Skerka, C. CFHR gene variations provide insights in the pathogenesis of the kidney diseases atypical hemolytic uremic syndrome and C3 glomerulopathy. J. Am. Soc. Nephrol. 31, 241–256 (2020).
Article CAS PubMed PubMed Central Google Scholar
Fakhouri, F. & Frémeaux-Bacchi, V. Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics. Nat. Rev. Nephrol. 17, 543–553 (2021).
Article CAS PubMed Google Scholar
Vivarelli, M. et al. The role of complement in kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 106, 369–391 (2024).
Article CAS PubMed Google Scholar
Marsili, L., Duque, K. R., Bode, R. L., Kauffman, M. A. & Espay, A. J. Uncovering essential tremor genetics: the promise of long-read sequencing. Front. Neurol. 13, 821189 (2022).
Article PubMed PubMed Central Google Scholar
Tanudisastro, H. A., Deveson, I. W., Dashnow, H. & MacArthur, D. G. Sequencing and characterizing short tandem repeats in the human genome. Nat. Rev. Genet. 25, 460–475 (2024).
Article CAS PubMed Google Scholar
Ayasreh, N. et al. Autosomal dominant tubulointerstitial kidney disease: clinical presentation of patients with ADTKD-UMOD and ADTKD-MUC1. Am. J. Kidney Dis. 72, 411–418 (2018).
Kirby, A. et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat. Genet. 45, 299–303 (2013).
Article CAS PubMed PubMed Central Google Scholar
Ekici, A. B. et al. Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in Mucin 1 or uromodulin. Kidney Int. 86, 589–599 (2014).
Article CAS PubMed Google Scholar
Blumenstiel, B. et al. Development and validation of a mass spectrometry-based assay for the molecular diagnosis of Mucin-1 kidney disease. J. Mol. Diagn. 18, 566–571 (2016).
Article CAS PubMed Google Scholar
Yamamoto, S. et al. Analysis of an ADTKD family with a novel frameshift mutation in MUC1 reveals characteristic features of mutant MUC1 protein. Nephrol. Dial. Transpl. 32, 2010–2017 (2017).
Saei, H. et al. VNtyper enables accurate alignment-free genotyping of MUC1 coding VNTR using short-read sequencing data in autosomal dominant tubulointerstitial kidney disease. iScience 26, 107171 (2023).
Article CAS PubMed PubMed Central Google Scholar
Bensouna, I. et al. Systematic screening of autosomal dominant tubulointerstitial kidney disease–MUC1 27dupC pathogenic variant through exome sequencing. J. Am. Soc. Nephrol. 36, 256–263 (2024).
Nurk, S. et al. The complete sequence of a human genome. Science 376, 44–53 (2022).
Article CAS PubMed PubMed Central Google Scholar
Liao, W.-W. et al. A draft human pangenome reference. Nature 617, 312–324 (2023).
Article CAS PubMed PubMed Central Google Scholar
Okada, E. et al. Detecting MUC1 variants in patients clinicopathologically diagnosed with having autosomal dominant tubulointerstitial kidney disease. Kidney Int. Rep. 7, 857–866 (2022).
Article PubMed PubMed Central Google Scholar
Ali, H. et al. PKD1 duplicated regions limit clinical utility of whole exome sequencing for genetic diagnosis of autosomal dominant polycystic kidney disease. Sci. Rep. 9, 4141 (2019).
Article PubMed PubMed Central Google Scholar
Kolmogorov, M. et al. Scalable nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation. Nat. Methods 20, 1483–1492 (2023).
Article CAS PubMed PubMed Central Google Scholar
Martin, A. R. et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat. Genet. 51, 1560–1565 (2019).
Article CAS PubMed Google Scholar
Stark, Z. et al. Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution. Am. J. Hum. Genet. 108, 1551–1557 (2021).
Comments (0)